Insider · CIK 0001816210

Patel Sanjiv

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001816210

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-07	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−48.2K sh	$18.10	−$872K	471,301
2026-09-08	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−48.2K sh	$18.94	−$913K	519,500
2026-08-17	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−48.2K sh	$20.33	−$980K	567,699
2026-07-07	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−48.2K sh	$19.58	−$944K	615,898
2026-06-30	RLAYRelay Therapeutics, Inc.A Award	Director, President and CEO	AAward	+3,056 sh	$6.95	+$21.2K	664,097
2026-01-13	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.45M sh	—	—	1,450,000
2026-01-06	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−43.2K sh	$7.82	−$338K	661,041
2025-12-31	RLAYRelay Therapeutics, Inc.A Award	Director, President and CEO	AAward	+994 sh	$2.99	+$2,972.06	704,209
2025-11-03	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−62.1K sh	$7.00	−$435K	703,215
2025-07-09	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−42.7K sh	$3.57	−$153K	783,927
2025-07-09	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−18.6K sh	$3.57	−$66.5K	765,288
2025-06-30	RLAYRelay Therapeutics, Inc.A Award	Director, President and CEO	AAward	+5,000 sh	$2.94	+$14.7K	826,667
2025-04-23	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−18.7K sh	$2.97	−$55.4K	821,667
2025-04-23	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−42.8K sh	$2.97	−$127K	840,320
2025-02-13	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−75.3K sh	$3.70	−$279K	883,089
2025-02-11	RLAYRelay Therapeutics, Inc.A Award	Director, President and CEO	AAward	+332K sh	—	—	958,413
2025-02-11	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−140K sh	$3.85	−$540K	625,948
2025-01-23	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−125K sh	$4.78	−$598K	199,548
2025-01-22	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−125K sh	$4.80	−$600K	324,548
2025-01-21	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−125K sh	$4.52	−$565K	449,548
2025-01-10	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.11M sh	—	—	1,105,000
2024-12-16	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−100K sh	$5.00	−$500K	574,548
2024-07-26	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−36.7K sh	—	—	482,073
2024-07-26	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−36.7K sh	$9.07	−$333K	766,130
2024-07-26	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+36.7K sh	$5.04	+$185K	802,836
2024-07-25	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−50K sh	—	—	518,779
2024-07-25	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−50K sh	$9.16	−$458K	766,130
2024-07-25	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+50K sh	$5.04	+$252K	816,130
2024-06-30	RLAYRelay Therapeutics, Inc.A Award	Director, President and CEO	AAward	+2,108 sh	$5.54	+$11.7K	766,130
2024-01-16	RLAYRelay Therapeutics, Inc.A Award	Director, President and CEO	AAward	+762K sh	—	—	764,022
2023-06-30	RLAYRelay Therapeutics, Inc.A Award	Director, President and CEO	AAward	+1,662 sh	$10.68	+$17.8K	1,662
2023-02-09	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−14K sh	$20.55	−$288K	0
2023-02-09	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14K sh	$5.04	+$70.6K	14,000
2023-02-09	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14K sh	—	—	568,779
2023-02-08	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−14K sh	$20.98	−$294K	0
2023-02-08	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14K sh	—	—	582,779
2023-02-08	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14K sh	$5.04	+$70.6K	14,000
2023-02-07	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14K sh	$5.04	+$70.6K	14,000
2023-02-07	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14K sh	—	—	596,779
2023-02-07	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−14K sh	$21.45	−$300K	0
2023-01-19	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+28K sh	$5.04	+$141K	282,554
2023-01-19	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−28K sh	$20.02	−$561K	254,554
2023-01-19	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−28K sh	—	—	610,779
2023-01-18	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+28K sh	$5.04	+$141K	282,554
2023-01-18	RLAYRelay Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−28K sh	$20.87	−$584K	254,554
2023-01-18	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−28K sh	—	—	638,779
2023-01-17	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+702K sh	—	—	701,680
2023-01-17	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+28K sh	$5.04	+$141K	282,554
2023-01-17	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+702K sh	—	—	701,680
2023-01-17	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−28K sh	—	—	666,779

Recent filings

Accepted (ET)
Oct 8 17:294
Patel Sanjiv0001193125-26-418096
SEC(opens sec.gov)
Sep 94
Patel Sanjiv0001193125-26-386455
SEC(opens sec.gov)
Aug 184
Patel Sanjiv0001193125-26-355502
SEC(opens sec.gov)
Jul 84
Patel Sanjiv0001193125-26-298681
SEC(opens sec.gov)
Jan 154
Patel Sanjiv0001193125-26-014109
SEC(opens sec.gov)
Jan 74
Patel Sanjiv0001193125-26-006328
SEC(opens sec.gov)
Nov 44
Patel Sanjiv0001193125-25-264700
SEC(opens sec.gov)
Jul 104
Patel Sanjiv0000950170-25-095093
SEC(opens sec.gov)
Jul 14
Patel Sanjiv0000950170-25-092305
SEC(opens sec.gov)
Apr 244
Patel Sanjiv0000950170-25-057996
SEC(opens sec.gov)
Feb 134
Patel Sanjiv0000950170-25-020272
SEC(opens sec.gov)
Jan 234
Patel Sanjiv0000950170-25-008451
SEC(opens sec.gov)

Companies

Address

C/O RELAY THERAPEUTICS, INC. 60 HAMPSHIRE STREET

CAMBRIDGE, MA, 02139